Adaptive Innovations has emerged from stealth with a $50 million Series A funding round to scale its AI-native clinical operations outside of Texas. The investment, led by California venture capital firm Felicis, brings the startup's total funding to $60 million following a previously undisclosed $10 million seed round in 2025. Instead of operating as a traditional software vendor, the company operates directly as the healthcare provider, using its proprietary artificial intelligence platform to automate intake, scheduling, documentation, and billing for its own clinical workforce.
Launched within the past 18 months, Adaptive already serves over 500 healthcare organizations across Texas, including major hospital systems, and has emerged as the leading home health provider for Blue Cross Blue Shield Texas patients. To build its proprietary platform, the startup paired legacy home healthcare operators with an AI research team recruited from Palantir, Jane Street, McKinsey, Harvard, Stanford, and the U.S. Army Rangers. Co-Founder Logan Stinson stated, "All of our solutions are being applied to our own patients instead of other companies."
The deployment of automated workflows has cut clinician documentation time by 80% across more than 100,000 completed patient home visits. This administrative reduction has lowered Adaptive's patient rehospitalization rate to under 5%, compared to the 11% industry average. The company intends to use the capital infusion to expand its clinical workforce and geographic footprint into what Stinson characterized as a "$100 billion industry that will double in 10 years."
